CloudFiler provides filing and searching in both New and Classic Outlook on all phones & tablets, all popular browsers, Macs and ARM based devices.
Created Microsoft's new web Add-in technology by the architect of the Oasys email management system previously owned by Arup Group Ltd and the Excitech Mail system owned by Symetri and latterly Pentagon.
File to: the cloud, Windows folders, SharePoint, OneDrive, Egnyte, Autodesk Forma, Bentley ProjectWise, etc.
Favoured by the biggest businesses globally.
Learn more

TE Recruit™ is a modern recruiting platform for staffing agencies, executive search firms, and independent recruiters that need an applicant tracking system and CRM without unnecessary complexity.
Built by Top Echelon, TE Recruit centralizes candidate records, company and contact data, job orders, communications, tasks, pipelines, and placement activity. Recruiters can manage business development and talent acquisition from the same system, while owners and managers gain clearer insight into activity, progress, and performance.
The platform supports configurable workflows, email sequencing, resume parsing, job posting, sourcing, reporting, and automation that reduces repetitive work. AI People Search uses semantic technology to uncover relevant candidates across related experience, skills, and job titles rather than relying only on exact keywords. It complements traditional Boolean search and is available with TE Recruit Pro.
TE Recruit connects with email, job boards, calling and texting providers, and other tools used across the recruiting technology stack. Pro customers can also use the open API to build custom integrations, exchange data between systems, and support more advanced workflows.
Guided onboarding, training, and responsive customer support are included, helping teams implement the platform and adapt it as their recruiting business evolves.
Firms can also add TE Network™, Top Echelon’s split-placement recruiter network. Its integrated Network Feed allows TE Recruit users to access shared candidates, additional job orders, and recruiter collaboration opportunities without leaving the ATS.
TE Recruit is a strong fit for recruiting businesses seeking flexible technology, practical AI, connected workflows, reliable support, and more ways to t
Learn more
Noodle Biomedical Literature Discovery
Noodle serves as Helena Bioinformatics' publicly accessible read-only platform for uncovering biomedical literature. This service enables users to search for topics and publications, inspect PMIDs, DOIs, and PMCIDs, as well as navigate through citation or semantic literature clusters in a limited manner. The publicly available MCP interface allows users to delve into research articles using a well-documented set of seven tools, though it does not permit any writing capabilities. Noodle is specifically tailored for enhancing scientific discovery and conducting literature reviews. Importantly, it does not offer any medical diagnosis, treatment advice, or the ability to crawl the web without restrictions, ensuring that its focus remains solely on literature exploration. Researchers can rely on Noodle for efficient access to relevant academic information.
Learn more
StrandOmics
Efficiently generating reports for NGS-based clinical tests necessitates a well-established and sophisticated platform that can automatically prioritize variants, interpret clinical data, and create comprehensive reports. Strand Omics serves as a rapid, HIPAA-compliant cloud platform that enhances our clinical diagnostics efforts, having been refined over four years through the analysis of more than 10,000 clinical reports and numerous peer-reviewed studies. This platform integrates advanced bioinformatics algorithms with curated databases, intuitive visualization tools, and robust reporting features. It is designed with specialized workflows tailored for both rare inherited conditions and somatic tumor profiling assays. Additionally, the system boasts a library of over 10,000 somatic variants that have been curated for their oncogenic potential, alongside 100 genes selected for their druggability across various cancer types, as well as 500 drugs that have been validated for efficacy against multiple cancers. Furthermore, its comprehensive approach ensures that healthcare professionals have access to critical data, ultimately facilitating informed decision-making in patient care.
Learn more